ライフサイエンスコーパス: venous sinus

1 a consequence of thrombosis within the dural venous sinuses.

2 trigeminal ganglion that innervate the dural venous sinuses.

3 porting cerebrospinal fluid (CSF) into dural venous sinuses.

4 Cerebral venous sinus abnormalities associated with the disorder

5 The large venous sinuses and dura mater are pain-sensitive and are

6 lity indexes from 13 major arteries and four venous sinuses and total cerebral blood flow were collec

7 ected in the pia mater, in the arachnoid, in venous sinuses, and among the layers of the dura mater.

8 networks, which are patterned alongside the venous sinuses, are also affected.

9 ature, rotation of the horns of the systemic venous sinus around the pulmonary portal, expansion of t

10 ne produced by the nearby auditory canal and venous sinus artifacts, an observation that may account

11 in the choroid plexus, pituitary gland, and venous sinuses as expected from the pharmacology of dihy

12 hlight the role of the skull bone marrow and venous sinuses as pivotal sites for peripheral and centr

13 s in mice and humans that aligned with dural venous sinuses but not with nasal CSF outflow, and we di

14 pread include hematogenous dissemination via venous sinuses, cerebrospinal fluid seeding in high-grad

15 implication that individuals with increased venous sinus compliance may be at increased risk of deve

16 les which create artery, vein, and cavernous venous sinus (CVS) segmentation masks from unlabeled CTA

17 0) nor predominance of unilateral transverse venous sinus drainage (R(2) = 0.07, p = 0.45) was relate

18 This paradigm is exemplified by the dural venous sinus IgA defense system, where the antibody repe

19 w dural lymphatic structures along the dural venous sinuses in dorsal regions and along cranial nerve

20 cerebri because placing a stent in stenosed venous sinuses is a novel treatment option in patients w

21 of humans and closely related primates: the venous sinus-lining or littoral cell (LC).

22 ynostosis and mutations in TWIST1 have dural venous sinus malformations.

23 h protein expression in liver sinusoids, the venous sinuses of the red pulp in spleen, and the medull

24 g to the presence of a fracture near a dural venous sinus or jugular bulb or a high index of clinical

25 if there is a fracture extending to a dural venous sinus or jugular bulb.

26 tions between branches of dural arteries and venous sinuses or veins.

27 with the endothelial lining of the meningeal venous sinus permits direct exchange of small solutes be

28 degree of narrowing of 1 or both transverse venous sinuses (r=-0.56, p=0.03).

29 hy of these vessels, running alongside dural venous sinuses, recapitulates the meningeal lymphatic sy

30 These cells are positioned adjacent to dural venous sinuses: regions of slow blood flow with fenestra

31 vessels in close anatomic proximity to dural venous sinuses, required for a functional meningeal lymp

32 Partial forms' lack significant shared dural venous sinuses (SDVS) and 'Total forms' with SDVS also e

33 ella, optic nerve tortuosity, and transverse venous sinus stenosis detected on MRI.

34 vitamin A, adipokines, sleep disorders, and venous sinus stenosis in the pathogenesis of IIH.

35 We retrospectively evaluated cerebral venous sinus stenosis using the conduit Farb score (CFS)

36 Bilateral transverse venous sinus stenosis was present in 6 of 198 patients (

37 include venous sinus stenting in cases with venous sinus stenosis, and bariatric surgery for weight

38 tonsillar descent, and bilateral transverse venous sinus stenosis.

39 as cerebrospinal fluid diversion procedures, venous sinus stenting and bariatric surgery but there ar

40 Venous sinus stenting could be a treatment option for ma

41 where in the treatment paradigm endovascular venous sinus stenting falls is unknown.

42 Emerging procedures include venous sinus stenting in cases with venous sinus stenosi

43 Finally, venous sinus stenting should be compared in head-to-head

44 s also been an emerging interest in cerebral venous sinus stenting, though its role and utility remai

45 shunting procedures and cerebral transverse venous sinus stenting.

46 approach for a subset of IIH patients: dural venous sinus stenting.

47 series that looked at patients treated with venous sinus stents show encouraging results in decreasi

48 onauts, but the impact on intracranial dural venous sinus structures remains unknown.

49 volume vs astronauts without SANS for all 3 venous sinus structures: superior sagittal sinus (13.40%

50 In some rare cases, cerebral venous sinus thromboses (CVST) have been reported as a s

51 rare, and sometimes fatal, cases of cerebral venous sinus thrombosis (CVST) and thrombocytopenia foll

52 Cerebral venous sinus thrombosis (CVST) is a rare but life-threat

53 Cerebral venous sinus thrombosis (CVST) with thrombocytopenia, a

54 re subsets of the primary outcomes: cerebral venous sinus thrombosis (CVST), ischaemic stroke, myocar

55 Cerebral venous sinus thrombosis (CVST), though a recognized comp

56 ombotic thrombocytopenia (VITT), is cerebral venous sinus thrombosis (CVST).

57 gesting a possible association with cerebral venous sinus thrombosis (CVST).

58 nts included pulmonary embolism and cerebral venous sinus thrombosis (n = 1 for each).

59 arditis (0%; 95% CI, 0%-0.01%), and cerebral venous sinus thrombosis (no individuals) consistent with

60 CPyV encephalopathy associated with cerebral venous sinus thrombosis and disseminated primary JCPyV i

61 es must also be considered, such as cerebral venous sinus thrombosis and reversible cerebral vasocons

62 Clinical settings were venous sinus thrombosis and seizure (n = 3), hemiplegic

63 sex- and age-adjusted incidence of cerebral venous sinus thrombosis before the COVID-19 pandemic wit

64 consecutive patients diagnosed with cerebral venous sinus thrombosis between January 1987 and March 2

65 participating in the International Cerebral Venous Sinus Thrombosis Consortium from Finland, the Net

66 bosis, with the most frequent being cerebral venous sinus thrombosis in combination with pulmonary em

67 Cases of cerebral venous sinus thrombosis in combination with thrombocytop

68 venience sample of 93 patients with cerebral venous sinus thrombosis included in the laboratory analy

69 subarachnoid hemorrhage and extensive dural venous sinus thrombosis involving the superior sagittal

70 a safe and effective treatment for cerebral venous sinus thrombosis not responding to anticoagulatio

71 In patients with cerebral venous sinus thrombosis prior to the COVID-19 pandemic,

72 t case of coinciding cerebral infarction and venous sinus thrombosis unveiling the diagnosis of celia

73 No dural venous sinus thrombosis was detected for any astronaut.

74 e evident on imaging, but transient cerebral venous sinus thrombosis was present.

75 Rates of cerebral venous sinus thrombosis were higher than otherwise expec

76 orway, Germany, and the UK reported cerebral venous sinus thrombosis with thrombocytopenia and anti-p

77 d Ad26.COV2.S COVID-19 vaccines and cerebral venous sinus thrombosis with thrombocytopenia.

78 symptoms and were confirmed to have cerebral venous sinus thrombosis, 12 (30%) had clinical deteriora

79 ry occlusion and left transverse and sigmoid venous sinus thrombosis, along with left jugular vein th

80 meningitis, ischemic and hemorrhagic stroke, venous sinus thrombosis, and endothelialitis.

81 er-associated deep vein thrombosis, cerebral venous sinus thrombosis, and for patients with atrial fi

82 , central retinal artery occlusion, cerebral venous sinus thrombosis, and left ventricular thrombus.

83 I], 1.4 to 5.2) among patients with cerebral venous sinus thrombosis, by a factor of 1.7 (95% CI, 1.3

84 , unruptured intracranial aneurysm, cerebral venous sinus thrombosis, cervical artery dissection, acu

85 increased alanine aminotransferase, cerebral venous sinus thrombosis, grade 3 increased amylase, and

86 myocardial infarction, Bell palsy, cerebral venous sinus thrombosis, Guillain-Barre syndrome, myocar

87 equency of stroke (arterial, n = 3; cerebral venous sinus thrombosis, n = 4), thrombocytopenia (media

88 of clinical manifestations included cerebral venous sinus thrombosis, splanchnic vein thrombosis, art

89 f intracranial hypertension such as cerebral venous sinus thrombosis.

90 Diagnosis of cerebral venous sinus thrombosis.

91 Dural venous sinus volumes before and after spaceflight.